Kala Bio (KALA) Current Deferred Revenue (2021 - 2025)

Kala Bio has disclosed Current Deferred Revenue across 5 years of filings, most recently posting $546000.0 for Q1 2025.

• In Q1 2025, Current Deferred Revenue changed N/A year-over-year to $546000.0; the TTM figure through Mar 2025 stood at $546000.0 (changed N/A YoY), while the FY2024 annual figure was $637000.0, down 40.74% from the prior year.
• Current Deferred Revenue came in at $546000.0 for Q1 2025 at Kala Bio, down from $637000.0 in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $7.0 million in Q4 2021 to a low of $219000.0 in Q2 2022.
• Average Current Deferred Revenue over 5 years is $2.5 million, with a median of $2.3 million recorded in 2024.
• Year-over-year, Current Deferred Revenue surged 1812.79% in 2023 and tumbled 89.28% in 2024.
• Over 5 years, Current Deferred Revenue stood at $7.0 million in 2021, then tumbled by 40.23% to $4.2 million in 2022, then sank by 74.34% to $1.1 million in 2023, then plunged by 40.74% to $637000.0 in 2024, then fell by 14.29% to $546000.0 in 2025.
• Per Business Quant data, the three most recent Current Deferred Revenue figures were $546000.0 in Q1 2025, $637000.0 in Q4 2024, and $314000.0 in Q3 2024.